Imfinzi-Imjudo dual immunotherapy offers new option for 1st-line treatment of liver cancer < Pharma < Article
As AstraZeneca launches Imjudo (tremelimumab) without health insurance coverage in May, Korean liver cancer patients will likely have...
Pharma
Bausch Health files patent lawsuit against Amneal Pharma for its liver disease drug – News Healthcare
Bausch Health Companies Inc. along with its gastroenterology business, Salix Pharmaceuticals, Inc., has filed a lawsuit in the United States...
USFDA approves first treatment for patients with liver scarring due to Fatty Liver Disease – Pharma News
The U.S. Food and Drug Administration (USFDA) has approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis...
